TrialAnnals of the rheumatic diseases2007

Infliximab in patients with systemic vasculitis that is difficult to treat: poor outcome and significant adverse effects.

Shirish R Sangle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.